BR9911917A - Composições compreendendo análogos de gaba e cafeìna - Google Patents
Composições compreendendo análogos de gaba e cafeìnaInfo
- Publication number
- BR9911917A BR9911917A BR9911917-0A BR9911917A BR9911917A BR 9911917 A BR9911917 A BR 9911917A BR 9911917 A BR9911917 A BR 9911917A BR 9911917 A BR9911917 A BR 9911917A
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- gaba
- caffeine
- analogs
- caffeine analogs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Patente de Invenção: <B>"COMPOSIçõES COMPREENDENDO ANáLOGOS DE GABA E CAFEìNA"<D>. Composições que compreendem um análogo do GABA, como a gabapentina ou a pregabalina em combinação com cafeína estão descritas. As composições são usadas para o tratamento da dor em mamíferos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9213198P | 1998-07-09 | 1998-07-09 | |
PCT/US1999/013670 WO2000002562A1 (en) | 1998-07-09 | 1999-06-18 | Compositions comprising gaba analogs and caffeine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9911917A true BR9911917A (pt) | 2001-03-27 |
Family
ID=22231777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9911917-0A BR9911917A (pt) | 1998-07-09 | 1999-06-18 | Composições compreendendo análogos de gaba e cafeìna |
Country Status (13)
Country | Link |
---|---|
US (1) | US6326374B1 (pt) |
EP (1) | EP1094817A1 (pt) |
JP (1) | JP2002520286A (pt) |
KR (1) | KR20010071777A (pt) |
AU (1) | AU772156B2 (pt) |
BR (1) | BR9911917A (pt) |
CA (1) | CA2332915C (pt) |
ID (1) | ID28277A (pt) |
NO (1) | NO20010119L (pt) |
NZ (1) | NZ508490A (pt) |
PL (1) | PL345340A1 (pt) |
WO (1) | WO2000002562A1 (pt) |
ZA (1) | ZA200007168B (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ332762A (en) | 1996-07-24 | 2000-09-29 | Warner Lambert Co | Isobutylgaba and its derivatives for the treatment of pain |
US6992109B1 (en) * | 1999-04-08 | 2006-01-31 | Segal Catherine A | Method for the treatment of incontinence |
JP2002541215A (ja) * | 1999-04-09 | 2002-12-03 | ユーロ−セルティック エス. ア. | ナトリウムチャネル遮断薬組成物およびその使用 |
US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
WO2003020273A2 (en) * | 2001-09-03 | 2003-03-13 | Newron Pharmaceuticals Spa | Pharmaceutical composition comprising gabapentin or an analogue thereof and an $g(a)-aminoamide and its analgesic use |
JP2007528893A (ja) * | 2004-03-12 | 2007-10-18 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | C1対称ビスホスフィンリガンド及びプレガバリンの不斉合成におけるそれらの使用 |
BRPI0508998A (pt) * | 2004-04-01 | 2007-09-04 | Warner Lambert Co | preparação de fosfolanos p-quirogênicos e seu uso em sìntese assimétrica |
ME01067B (me) * | 2004-06-21 | 2012-10-20 | Warner Lambert Co | Dobijanje pregabalina i srodnih jedinjenja |
AU2005282028B2 (en) * | 2004-09-10 | 2011-03-24 | Newron Pharmaceuticals S.P.A. | (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
CA2629065C (en) | 2005-12-22 | 2013-08-06 | Newron Pharmaceuticals S.P.A. | 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
US7645767B2 (en) * | 2006-08-31 | 2010-01-12 | Trinity Laboratories, Inc. | Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy |
CH699327B1 (de) | 2007-02-14 | 2010-03-15 | Oerlikon Heberlein Temco Wattw | Vorrichtung zum gleichzeitigen Behandeln von mehreren multifilen Fäden. |
WO2009021058A2 (en) | 2007-08-06 | 2009-02-12 | Trinity Labortories, Inc. | Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy |
JP2010043063A (ja) | 2008-05-09 | 2010-02-25 | Agency For Science Technology & Research | 川崎病の診断及び治療 |
US20100190752A1 (en) * | 2008-09-05 | 2010-07-29 | Gruenenthal Gmbh | Pharmaceutical Combination |
WO2011141923A2 (en) | 2010-05-14 | 2011-11-17 | Lupin Limited | Improved synthesis of optically pure (s) - 3-cyano-5-methyl-hexanoic acid alkyl ester, an intermediate of (s)- pregabalin |
WO2012059797A1 (en) | 2010-11-04 | 2012-05-10 | Lupin Limited | Process for synthesis of (s) - pregabalin |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4656177A (en) | 1982-07-22 | 1987-04-07 | Analgesic Associates | Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |
US5248678A (en) | 1992-06-30 | 1993-09-28 | Fractal Laboratories, Inc. | Methods for increasing arousal and alertness and for the amelioration of comatose states |
EP0717624A1 (en) * | 1993-09-07 | 1996-06-26 | The Procter & Gamble Company | Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine |
US5443838A (en) * | 1993-09-15 | 1995-08-22 | Koenig, Jr.; Steven M. | Nutritional supplementation system |
CA2244912C (en) * | 1996-03-14 | 2005-07-12 | Warner-Lambert Company | Novel substituted cyclic amino acids as pharmaceutical agents |
ES2241055T3 (es) | 1996-08-23 | 2005-10-16 | Endo Pharmaceuticals Inc | Composicion que contiene un anticonvulsionante para tratar el dolor neuropatico. |
ATE361909T1 (de) | 1996-10-23 | 2007-06-15 | Warner Lambert Co | Substituierte gamma-aminobuttersäurederivate als arzneimittel |
DE69832712T2 (de) | 1997-09-08 | 2006-06-22 | Warner-Lambert Company Llc | Analgetische zusammensetzung enthaltend antiepileptische arzneistoffe und deren verwendungen |
-
1999
- 1999-06-18 JP JP2000558822A patent/JP2002520286A/ja not_active Withdrawn
- 1999-06-18 ID IDW20010054A patent/ID28277A/id unknown
- 1999-06-18 AU AU46910/99A patent/AU772156B2/en not_active Ceased
- 1999-06-18 NZ NZ508490A patent/NZ508490A/en unknown
- 1999-06-18 KR KR1020017000260A patent/KR20010071777A/ko not_active Application Discontinuation
- 1999-06-18 CA CA002332915A patent/CA2332915C/en not_active Expired - Fee Related
- 1999-06-18 WO PCT/US1999/013670 patent/WO2000002562A1/en not_active Application Discontinuation
- 1999-06-18 EP EP99930357A patent/EP1094817A1/en not_active Ceased
- 1999-06-18 PL PL99345340A patent/PL345340A1/xx not_active Application Discontinuation
- 1999-06-18 US US09/743,371 patent/US6326374B1/en not_active Expired - Fee Related
- 1999-06-18 BR BR9911917-0A patent/BR9911917A/pt not_active Application Discontinuation
-
2000
- 2000-12-04 ZA ZA200007168A patent/ZA200007168B/en unknown
-
2001
- 2001-01-08 NO NO20010119A patent/NO20010119L/no unknown
Also Published As
Publication number | Publication date |
---|---|
ID28277A (id) | 2001-05-10 |
AU4691099A (en) | 2000-02-01 |
NO20010119D0 (no) | 2001-01-08 |
NO20010119L (no) | 2001-01-08 |
AU772156B2 (en) | 2004-04-08 |
EP1094817A1 (en) | 2001-05-02 |
KR20010071777A (ko) | 2001-07-31 |
PL345340A1 (en) | 2001-12-17 |
NZ508490A (en) | 2003-08-29 |
ZA200007168B (en) | 2002-03-04 |
JP2002520286A (ja) | 2002-07-09 |
CA2332915A1 (en) | 2000-01-20 |
WO2000002562A1 (en) | 2000-01-20 |
US6326374B1 (en) | 2001-12-04 |
CA2332915C (en) | 2006-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9911917A (pt) | Composições compreendendo análogos de gaba e cafeìna | |
BR9713400A (pt) | Processos e compostos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese. | |
UY24354A1 (es) | Composiciones farmacéuticas que contienen epinastina | |
BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
BRPI0411319A (pt) | compostos terapeuticamente ativos e sua utilização | |
BR9808348A (pt) | Alimento medicinal para diabéticos | |
SE9502167L (sv) | Insulinanalog-kompositioner | |
BR9900320A (pt) | Composição antimicrobiana | |
BR9714517A (pt) | Cicloalquila, lactama, lactona e compostos correlatos, composições farmacêuticas compreendendo os mesmos e processos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos | |
DE69905170T2 (de) | Thiazolopyrimidinderivate | |
ZA98214B (en) | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1. | |
DK0705100T3 (da) | Terapeutiske substituerede guanidiner | |
BR0212298A (pt) | Composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico | |
AR003589A1 (es) | Utilizacion de una cantidad eficaz de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento destinada paratratar la inflamacion, y un procedimiento de tratamiento cosmetico mediante una composicion cosmetica que contiene a dicho peptido. | |
BR9913072A (pt) | Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia | |
BR9712141A (pt) | Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas. | |
WO2002062304A3 (de) | Kosmetische und/oder pharmazeutische mittel acylierte aminosäure und proteinkondensat enthaltend. | |
BR0012058A (pt) | Combinação sinérgica: gabapentina e pregabalina | |
TR200000903T2 (tr) | Romatizmal arteritlerin tedavisine yönelik yöntem ve kompozisyonlar. | |
PT640098E (pt) | Gene de coronavirus canino e suas utilizacoesc | |
ATE344664T1 (de) | Verbesserte methode zur eradikation von helicobacter pylori | |
BR0206087A (pt) | Formulação de enxaguamento redutora para uso com ozÈnio no tratamento de cáries dentárias | |
DE69831737D1 (de) | Neurotrypsin | |
TWI262791B (en) | 6-methoxy-2-naphthylacetic acid prodrugs | |
EA199700032A1 (ru) | Дезинфицирующий состав "велтолен" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL: A61K 31/52, A61K 31/197, A61P 29/00, A61P 25/04 Ipc: A61K 31/52 (2007.10), A61K 31/197 (2007.10), A61P |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI. |